Los Alamos National Security and Biomagnetics Sign CRADA to Develop Optical Biosensor

Biomagnetics Diagnostics announced that it has signed a CRADA (Cooperative Research and Development Agreement) with Los Alamos National Security to develop an integrated optical biosensor system for detecting pathogens. Biomagnetics intends to introduce this novel technology into the public sector and will initially use it to target TB and cholera.

Under the agreement, the engineering and scientific staffs of Los Alamos will generate a duplicate copy of the bench-top biosensor platform and will test and optimize the current cholera assay. The team will then train and guide the scientific staff at Biomagnetics to recognize the potential sources from which samples of human cholera can be obtained. The team will also guide the scientific staff on how to use the cholera assays on human samples.

Biomagnetics Diagnostics’ CEO, Clayton Hardman, stated that the new deal expands the previously signed agreement with Los Alamos National Security, and provides them access to advanced biosensor technology. The pathogen detection equipment, optical biosensor, utilizes a sophisticated wave-guide technology to identify animal and human pathogens. The optical biosensor may help reduce cost and maximize the diagnosis’ availability, he said.